Plasma Cytokeratin-18 Fragment Level Reflects the Metabolic Phenotype in Obesity
Biomolecules · 2023
DOI: 10.3390/biom13040675 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Joanna Goralska und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Jagiellonian University Medical College, Skawinska 8, 31-066 Krakow, Poland. Hauptthemen laut MEDLINE: Insulin Resistance, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, Ministry of Science and Higher Education.
Abstract (Originalsprache)
There is growing interest in the non-invasive identification and monitoring of the outcome of liver damage in obese patients. Plasma cytokeratin-18 (CK-18) fragment levels correlate with the magnitude of hepatocyte apoptosis and have recently been proposed to independently predict the presence of non-alcoholic steatohepatitis (NASH). The aim of the study was to analyze the associations of CK-18 with obesity and related complications: insulin resistance, impaired lipid metabolism and the secretion of hepatokines, adipokines and pro-inflammatory cytokines. The study involved 151 overweight and obese patients (BMI 25–40), without diabetes, dyslipidemia or apparent liver disease. Liver function was assessed based on alanine aminotransferase (ALT), gamma-glutamyl transferase (GGT) and the fatty liver index (FLI). CK-18 M30 plasma levels, FGF-21, FGF-19 and cytokines were determined by ELISA. CK-18 values >150 U/l were accompanied by high ALT, GGT and FLI, insulin resistance, postprandial hypertriglyceridemia, elevated FGF-21 and MCP-1 and decreased adiponectin. ALT activity was the strongest independent factor influencing high CK-18 plasma levels, even after an adjustment for age, sex and BMI [β coefficient (95%CI): 0.40 (0.19–0.61)]. In conclusion, the applied CK-18 cut-off point at 150 U/l allows to distinguish between two metabolic phenotypes in obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Biochemistry, Jagiellonian University Medical College, Skawinska 8, 31-066 Krakow, Poland.
- Institute of Nursing and Midwifery, Jagiellonian University Medical College; Michałowskiego 12, 31-126 Krakow, Poland.
ORCID-Profile: Joanna Goralska, Agnieszka Micek
Förderung
- European Commission
- Ministry of Science and Higher Education
Zitieren
APA
Goralska, J., Razny, U., Gruca, A., Zdzienicka, A., Micek, A., Dembinska-Kiec, A., Solnica, B., & Malczewska-Malec, M. (2023). Plasma Cytokeratin-18 Fragment Level Reflects the Metabolic Phenotype in Obesity. Biomolecules. https://doi.org/10.3390/biom13040675
Vancouver
Goralska J, Razny U, Gruca A, Zdzienicka A, Micek A, Dembinska-Kiec A, et al. Plasma Cytokeratin-18 Fragment Level Reflects the Metabolic Phenotype in Obesity. Biomolecules. 2023. doi:10.3390/biom13040675
BibTeX
@article{Goralska2023,
author = {Goralska, Joanna and Razny, Urszula and Gruca, Anna and Zdzienicka, Anna and Micek, Agnieszka and Dembinska-Kiec, Aldona and Solnica, Bogdan and Malczewska-Malec, Malgorzata},
title = {Plasma Cytokeratin-18 Fragment Level Reflects the Metabolic Phenotype in Obesity},
journal = {Biomolecules},
year = {2023},
doi = {10.3390/biom13040675}
}
EUVIMED